FDA Clearance Tracker · P870072-S027
THORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE (IVAD)
Last checked: Nov 20, 2026Latest source record: Aug 3, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Aug 3, 2004
Approved
Time to decision
210 days
Received Jan 6, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P870072-S027
- Device name
- THORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE (IVAD)
- Applicant
- Thoratec Laboratories Corp.
- Applicant location
- Berkeley, CA
- Received
- Jan 6, 2004
- Decided
- Aug 3, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P870072
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE THORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE (IVAD) AS AN ALTERNATE VAD BLOOD PUMP FOR USE IN THE APPROVED THORATEC VENTRICULAR ASSIST DEVICE SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME THORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE AND IS INDICATED FOR USE IN BRIDGE TO TRANSPLANT PATIENTS WHO MEET ALL OF THE FOLLOWING CRITERIA: CANDIDATE FOR CARDIAC TRANSPLANTATION, IMMINENT RISK OF DYING BEFORE DONOR HEART PROCUREMENT, DEPENDENCE ON, OR INCOMPLETE RESPONSE TO, CONTINUED VASOPRESSOR SUPPORT. IT IS ALSO INDICATED FOR POSTCARDIOTOMY RECOVERY PATIENTS WHO ARE UNABLE TO BE WEANED FROM CARDIOPULMONARY BYPASS. IN ADDITION, THE IVAD IS DESIGNED TO BE COMPATIBLE WITH BOTH THE DUAL DRIVER CONSOLE AND TLC-II PORTABLE VAD DRIVER.
Source documents
Other decisions for Thoratec Laboratories Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.